Advertisement

Multiple Pregnancy Update: Issues Following Assisted Reproductive Techniques

  • Lisa J. KnightEmail author
  • Lisa A. Joels
  • Myles J. O. Taylor
Chapter

Abstract

Multi-fetal conceptions are the single most important determinant of pregnancy and long-term outcomes for both the mother and baby and these risks increase exponentially with the number of fetuses. One in five IVF pregnancies results in multiple gestation compared with one in 80 from natural conceptions. Multiple pregnancy is considered to be the most common adverse outcome and the largest health risk associated with assisted reproductive technologies. High multiple pregnancy rates are preventable, particularly in light of elective single embryo transfer and modified drug regimes for stimulated IVF cycles. Risks to the fetuses in multiple pregnancies depend greatly on chorionicity and amnionicity. Monochorionic pregnancies are at a much higher risk of adverse outcome for the fetuses in utero and during delivery. Optimising antenatal monitoring and careful intrapartum planning and execution is essential for a safe outcome for mother and babies. Developments in assisted reproductive technologies in the prevention of multiple pregnancies are also discussed.

Keywords

Multiple Pregnancy Assisted Reproductive Technology IVF Elective single embryo transfer 

References

  1. 1.
    NICE Guidelines CG156: fertility: assessment and treatment for people with fertility problems. 2013.Google Scholar
  2. 2.
    Human Fertilisation and Embryology Authority (HFEA). Improving outcomes for fertility patients: multiple births. London: HFEA; 2015. http://www.hfea.gov.uk/docs/Multiple_Births_Report_2015.pdf.
  3. 3.
    Human Fertilisation and Embryology Authority (HFEA). Fertility treatment 2014: trends and figures. London: HREA; 2016. http://www.hfea.gov.uk/docs/HFEA_Fertility_treatment_Trends_and_figures_2014.pdf.
  4. 4.
    Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(5):485–503.CrossRefPubMedGoogle Scholar
  5. 5.
    Hansen M, Colvin L, Petterson B, Kurinczuk JJ, deKlerk N, Bower C. Twins born following assisted reproductive technology: perinatal outcome and admission to hospital. Hum Reprod. 2009;24(9):2321–31.CrossRefPubMedGoogle Scholar
  6. 6.
    RCOG Press and British Fertility Society (BFS). In vitro fertilisation: perinatal risks and early childhood outcomes. Scientific Impact Paper No. 8. May 2012.Google Scholar
  7. 7.
    NICE Guidelines CG129: multiple pregnancy: the management of twin and triplet pregnancies in the antenatal period. 2011.Google Scholar
  8. 8.
    Taylor M, Fisk N. Multiple pregnancy. Obstet Gynaecol. 2000;2:2–10.Google Scholar
  9. 9.
    Braude P. One child at a time. Reducing multiple births after IVF. Report of the Expert Group on Multiple Births after IVF. London: HFEA; 2006. http://www.oneatatime.org.uk/images/MBSET_report_Final_Dec_06.pdf.Google Scholar
  10. 10.
    Homberg R. Ovulation induction and controlled ovarian stimulation. Switzerland: Springer International Publishing; 2014.CrossRefGoogle Scholar
  11. 11.
    Fauser BC, Devroey P, Macklon NS. Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet. 2005;365:1807–16.CrossRefPubMedGoogle Scholar
  12. 12.
    Gorthi S, Balen AH, Tang T. Current issues in ovulation induction. Obstet Gynaecol. 2012;14:188–96.CrossRefGoogle Scholar
  13. 13.
    Rowe PJ, Comhaire FH, Hargreave TB, Mellows HJ. WHO manual for the standardized investigation and diagnosis of the infertile couple. Cambridge: Cambridge University Press; 1997.Google Scholar
  14. 14.
    Baden AH, Jacobs HS. Infertility in practice. New York: Churchill Livingstone; 1997.Google Scholar
  15. 15.
    Casper RF, Mitwally MF. Review: aromatase inhibitors for ovulation induction. J Clin Endocrinol Metabol. 2006;91:760–71.CrossRefGoogle Scholar
  16. 16.
    Nandi A, Homburg R. Unexplained subfertility: diagnosis and management. Obstet Gynaecol. 2016. doi: 10.1111/tog.12253.Google Scholar
  17. 17.
    Ragni G, Caliari I, Nicolosi AE, Arnoldi M, Somigliana E, Crosignani PG. Preventing high-order multiple pregnancies during controlled ovarian hyperstimulation and intrauterine insemination: 3 years’ experience using low-dose recombinant follicle-stimulating hormone and gonadotropin releasing hormone antagonists. Fertil Steril. 2006;85:619–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Vitthala S, Gelbaya TA, Brison DR, Fitzgerald CT, Nardo LG. The risk of monozygotic twins after assisted reproductive technology: a systematic review and metanalysis. Hum Reprod Update. 2009;15(1):45–55.CrossRefPubMedGoogle Scholar
  19. 19.
    RCOG. Green Top Guideline No. 51. Management of monochorionic twin pregnancy. London: RCOG Press; 2008.Google Scholar
  20. 20.
    Seoud MA, Toner JP, Kruithoff C, Muasher SJ. Outcome of twin, triplet, and quadruplet in vitro fertilization pregnancies: the Norfolk experience. Fertil Steril. 1992;57(4):825–34.CrossRefPubMedGoogle Scholar
  21. 21.
    Ericson A, Källén B. Congenital malformations in infants born after IVF: a population-based study. Hum Reprod. 2001;16(3):504–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Best KE, Rankin J. Increased risk of congenital heart disease in twins in the North of England between 1998 and 2010. Heart. 2015;101(22):1807–12.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
  24. 24.
    Brinsden PR. Textbook of in vitro fertilization and assisted reproduction. Oxon: Taylor & Francis Group; 2005.CrossRefGoogle Scholar
  25. 25.
    Hope T. Medical ethics. A very short introduction. Oxford: Oxford University Press; 2004.CrossRefGoogle Scholar
  26. 26.
    Petterson B, Nelson KB, Watson L, Stanley F. Twins, triplets, and cerebral palsy in births in Western Australia in the 1980s. BMJ. 1993;307(6914):1239–43.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Wimalasundera RC. Selective reduction and termination of multiple pregnancies. Semin Fetal Neonatal Med. 2010;15(6):327–35.CrossRefPubMedGoogle Scholar
  28. 28.
    Bergh C, Moller A, Nilsson L, Wikland M. Obstetric Outcome and psychological follow-up of pregnancies after embryo reduction. Hum Reprod. 1999;14(8):2170–5.CrossRefPubMedGoogle Scholar
  29. 29.
    Taylor MJO, Fisk N. Management of twin-twin transfusion syndrome. In: High risk pregnancy. Blickenstein; 2005.Google Scholar
  30. 30.
    Smith RP, Denbow ML. Review: twin to twin transfusion syndrome. Obstet Gynaecol. 2006;8:1–6.CrossRefGoogle Scholar
  31. 31.
    Quintero RA, Morales WJ, Allen MH, Bornick PW, Johnson PK, Kruger M. Staging of twin-twin transfusion syndrome. J Perinatol. 1999;19:550–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Normal JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et al. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet. 2009;373(9680):2034–40.CrossRefGoogle Scholar
  33. 33.
    Hartley RS, Emanuel I, Hitti J. Perinatal mortality and neonatal morbidity rates among twin pairs at different gestational ages: optimal delivery timing at 37 to 38 weeks’ gestation. Am J Obstet Gynaecol. 2001;184(3):451–8.CrossRefGoogle Scholar
  34. 34.
    Dodd J, Crowther C, Haslam R, Robinson J. Elective birth at 37 weeks of gestation versus standard care for women with an uncomplicated twin pregnancy at term: the Twins Timing of Birth Randomised Trial. BJOG. 2012;119:964–74.CrossRefPubMedGoogle Scholar
  35. 35.
    Barrett JFR, Hannah ME, Hutton EF, Willan AR, Allen AC, Armson BA, Gafni A, Joseph KS, Mason D, Ohlsson A, Ross S, Sanchez JJ, Asztalos EV. A randomized trial of planned caesarean or vaginal delivery for twin pregnancy. N Engl J Med. 2013;369:1295–305.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Breathnach FM, McAuliffe FM, Geary M, Daly S, Higgins JR, Dornan J, Morrison JJ, Burke G, Higgins S, Dicker P, Manning F. Optimum timing for planned delivery of uncomplicated monochorionic and dichorionic twin pregnancies. Obstet Gynecol. 2012;119(1):50–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Kent EM, Breathnach FM, Gillan JE, McAuliffe FM, Geary MP, Daly S, Higgins JR, Hunter A, Morrison JJ, Burke G, Higgins S. Placental pathology, birthweight discordance, and growth restriction in twin pregnancy: results of the ESPRiT Study. Am J Obstet Gynecol. 2012;207(3):220–e1.CrossRefPubMedGoogle Scholar
  38. 38.
    Scientific Impact Paper. Multiple pregnancy following assisted reproduction. RCOG Press; 2011.Google Scholar
  39. 39.
    Blake DA, Farquhar CM, Johnson N, Proctor M. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database System Rev. 2007;(4):CD002118.Google Scholar
  40. 40.
    Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control. 2000;11:319–44.CrossRefPubMedGoogle Scholar
  41. 41.
    Vitek W, Robins JC. In vitro maturation. Obstet Gynaecol. 2013;15:215–9.CrossRefGoogle Scholar
  42. 42.
    Söderström-Anttila V, Salokorpi T, Pihlaja M, Serenius-Sirve S, Suikkari AM. Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod. 2006;21:1508–13.CrossRefPubMedGoogle Scholar
  43. 43.
    Campbell A, Fishel S, Bowman N, Duffy S, Pedler S, Fonte Lidemann Hickme C. Modeling a risk classification of aneuploidy in human embryos using non-invasive morphokinetics. Reprod BioMed Online. 2013;26(5):477–85.CrossRefPubMedGoogle Scholar
  44. 44.
    Vergow CG, Heymans MW, Hardson T, Sfontouris IA, Economou KA, Ahlstrom A, Rogberg L, Lainas TG, Sakkas D, Kieslinger DC, Kostelijk EH, Hompes PGA, Schats R, Lambalk CB. No evidence that embryo selection by near-infrared spectroscopy in addition to morphology is able to improve live birth rates: results from an individual patient data meta-analysis. Hum Reprod. 2014;29(3):455–61.CrossRefGoogle Scholar
  45. 45.
    Nardo LG, El-Toukhy T, Stewart J, Balen AH, Potdar N. British Fertility Society Policy and Practice Committee: adjuvants in IVF: evidence for good clinical practice. Hum Fertil. 2015;18(1):2–15.CrossRefGoogle Scholar
  46. 46.
    Dame Mary Warnock DBE. Department of Health and Social Security: report of the committee of inquire into human fertilisation and embryology. London: Her Majesty’s Stationary Office; 1984.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Lisa J. Knight
    • 1
    Email author
  • Lisa A. Joels
    • 2
  • Myles J. O. Taylor
    • 3
  1. 1.Department of Obstetrics and GynaecologyRoyal Devon and Exeter HospitalExeterUK
  2. 2.Royal Devon and Exeter NHS Foundation TrustCentre for Women’s Health, Wonford HospitalExeterUK
  3. 3.Royal Devon and Exeter NHS Foundation TrustCentre for Women’s HealthExeterUK

Personalised recommendations